Rapid Micro Biosystems Inc. Class A (RPID)
NASDAQ: RPIDIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
RPID stock chart
Technical analysisKey statistics
All statistics- Market cap
- $37.37M
- EPS (TTM)
- -$1.06
- Dividend yield
- None
- 52-week range
- 0.58 – 4.94
- Day range
- 0.735 – 0.7369
- Volume / Avg
- 1.45M / 577.05K
- Beta
- —
- Shares outstanding
- 46.34M
52-week range
RPID stock today
On Nov 20, RPID ended the session at $0.735, shedding $0.0003 (0.04%), versus the S&P 500's 3.70% decline. Volume was 2.5x the average at 1.45M shares, a sign of unusually heavy trading. Shares are 85.1% below their 52-week high of $4.94, set on Jan 29, 2026 and 26.7% above the 52-week low of $0.58, near the bottom of the past year's range.
RPID is down 74.7% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 82.4%. Rapid Micro Biosystems has posted a net loss over the last twelve months (EPS of -$1.06), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Rapid Micro Biosystems
Company profileRapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables.
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- CEO
- Mr. Robert G. Spignesi Jr.
- Headquarters
- Lexington, MA
- Employees
- 171
- IPO year
- 2021
- Website
- rapidmicrobio.com
Financial highlights
Full financialsIn fiscal 2025, Rapid Micro Biosystems generated $33.6 million in revenue, up 19.7% from fiscal 2024, its 3rd consecutive year of revenue growth. Rapid Micro Biosystems reported a net loss of $47.1 million, compared with a loss of $46.9 million a year earlier. Operating margin was -141.1%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $33.59M | $28.05M | $22.52M | $17.13M | $23.23M |
| Growth | +19.74% | +24.57% | +31.44% | -26.25% | +44.50% |
| Net income | $-47.12M | $-46.89M | $-52.47M | $-60.81M | $-73.52M |
| EPS (diluted) | $-1.05 | $-1.08 | $-1.22 | $-1.43 | $-3.94 |
Analyst forecast
ForecastConsensus (5 analysts)
strong_buy
Avg. price target
$5.75+682.31%
- Strong buy 0
- Buy 5
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 16, 2026
- EPS actual vs est.
- $-0.22 vs $-0.20
- Surprise
- -10.00%
RPID news
All RPID news- SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Rapid Micro Biosystems, Inc. (NASDAQ: RPID)PR Newswire
- Rapid Micro Biosystems, Inc. to be Acquired by Merck KGaA, Darmstadt, Germany for $0.75 Per ShareNasdaq
- Rapid Micro Biosystems Reports Third Quarter 2026 Financial ResultsGlobeNewswire
- Rapid Micro Biosystems Signs Definitive Agreement to be Acquired by Merck KGaA, Darmstadt, GermanyGlobeNewswire
- Rapid Micro Biosystems to Participate at the PDA Pharmaceutical Microbiology Conference 2026GlobeNewswire
Rapid Micro Biosystems peers
Industrials sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| HBIOHarvard Bioscience Inc. | 8.66 | -0.23% | $39.60M | vs RPID |
| PRPOPrecipio Inc. | 17.35 | -6.17% | $31.11M | vs RPID |
| EYPTEyePoint Inc. | 0.2342 | -11.36% | $26.65M | vs RPID |
| CIRCCircle8 Group Inc. | 0.1361 | -12.25% | $15.99M | vs RPID |
| BNGOBionano Genomics Inc. | 0.8222 | -7.11% | $11.50M | vs RPID |
| ASTCAstrotech Corporation (DE) | 3.50 | -0.85% | $7.45M | vs RPID |
| SEERSeer Inc. Class A | 1.36 | -1.81% | $75.91M | vs RPID |
| QTRXQuanterix Corporation | 1.96 | -3.45% | $93.06M | vs RPID |
Indexes, lists and sector
Rapid Micro Biosystems stock FAQ
What is Rapid Micro Biosystems's stock price today?
RPID last traded at $0.735 as of Nov 20, 4:00 PM EST, down 0.04% on the day. Prices are delayed at least 15 minutes.
Who is Rapid Micro Biosystems's CEO?
Mr. Robert G. Spignesi Jr. is the chief executive officer of Rapid Micro Biosystems Inc. Class A, which has about 171 employees.
What is the RPID 52-week high?
The 52-week high for RPID is $4.94 and the 52-week low is $0.58. The stock is currently 85.1% below its high.